Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

The Dow, up +0.56%, is the clear leader of this early 2026 action, outperforming other Indexes which finish the session lower ...

Eagle Point's EICC preferred looks attractive with an 8% coupon, strong asset coverage, and likely early call/refinance amid ...

Apple (AAPL) looks overvalued vs peers; DCF suggests limited upside due to slowing iPhone cycles. Read here for a detailed ...

Job openings unexpectedly fell for a second straight month in November, hitting 7.146 million vacancies according to the ...

Booz Allen Hamilton looks attractive after its recent sell-off, trading below historic P/E. Read the latest analysis on BAH ...

American Homes 4 Rent stock is a Hold despite strong rent growth as a proposed ban on institutional single-family home buying ...

Communication Services Select Sector SPDR ETF (XLC) offers the most attractive blend of value and growth for 2026, with a 38% ...

Robert Half Inc. shares have fallen 59% in a year and 80% from early 2022 highs. Click here to read why RHI stock is a Sell.

Gold and gold miners have a high hurdle to cross in 2026 after a very strong 2025, but there is reason to be optimistic ...

Novo Nordisk A/S is rated Buy with Wegovy pill seen as a potential catalyst to reignite growth & recapture market share. Read ...

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...